Furthermore, advanced NSCLC patients carrying the ERCC2 rs50872 C in combination with XRCC1 rs25487 A allele rendered the shortest MST and highest death risk for advanced NSCLC patients. Here, XRCC1 is linked to non-small cell lung carcinoma.